Topchoice Medical Co., Inc. (SHA:600763)
China flag China · Delayed Price · Currency is CNY
32.43
+0.10 (0.31%)
Sep 16, 2026, 3:00 PM CST

Topchoice Medical Co. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
614.92501.95501500.44548.27702.81
Depreciation & Amortization
195.17190.93203.41189.35173.31153.8
Other Amortization
68.7972.564.4555.2546.135
Loss (Gain) From Sale of Assets
-0.40.27-0.14-0.050.02
Asset Writedown & Restructuring Costs
0.370.360.860.420.510.21
Loss (Gain) From Sale of Investments
-146.09-47.33-47.84-60.19-38.3-56.13
Provision & Write-off of Bad Debts
4.9211.353.171.751.671.29
Other Operating Activities
124.75122.82114.15131.85117.71109.25
Change in Accounts Receivable
-49.37-42.73-28.94-37.77-45.07-46.88
Change in Inventory
-1.8310.22-3.74-1.9-2.55-2.68
Change in Accounts Payable
37.96-3.78-37.371.22-122.1236.97
Change in Other Net Operating Assets
-9.3-1.64-1.64-1.64-1.64-1.64
Operating Cash Flow
838.15810.72762.99841.02670.05939.41
Operating Cash Flow Growth
3.27%6.25%-9.28%25.52%-28.67%32.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-218.07-246.2-332.11-508.9-421.53-367.32
Sale of Property, Plant & Equipment
2.152.152.020.010.620.02
Cash Acquisitions
-555-15-27.73---
Divestitures
----0.03-131.95
Investment in Securities
5.2411.11-7.04-504.25-60.45-234.42
Other Investing Activities
-20.15-31.31-96.1-14.47-15.99-14
Investing Cash Flow
-785.83-279.24-324.97-887.63-497.35-483.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-5080280--
Long-Term Debt Repaid
--224.81-252.43-193.57-251.18-241.76
Lease Payments
-166.96-124.81-133.63-151.57-141.18-136.76
Net Debt Issued (Repaid)
-95.96-174.81-172.4386.43-251.18-241.76
Repurchase of Common Stock
-5.01--30.1-1-99.99-
Common Dividends Paid
--208.89-149.89-11.24-6.69-12.87
Other Financing Activities
-65.52-71.32-59.85-63.04-28.33-31.3
Financing Cash Flow
-166.49-455.02-412.2811.15-386.19-285.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-114.1676.4625.74-35.46-213.5169.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
620.09564.52430.88332.13248.52572.09
Free Cash Flow Growth
14.99%31.02%29.73%33.64%-56.56%6.33%
Free Cash Flow Margin
20.84%19.38%14.99%11.67%9.14%20.57%
Free Cash Flow Per Share
1.391.260.960.740.551.27
Levered Free Cash Flow
326.11330.95375.96331.44-199.6365.3
Unlevered Free Cash Flow
346.65353.36404.36365.82-168.32383.37
Free Cash Flow After Leases
453.13439.71297.24180.56107.33435.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
162.6153.52162.07142.52227.01105.67
Change in Working Capital
-24.26-42.12-76.0622.15-179.26-6.83